Gateway Investment Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.92M Sell
5,889
-651
-10% -$212K 0.02% 256
2025
Q1
$1.77M Sell
6,540
-843
-11% -$228K 0.02% 267
2024
Q4
$1.74M Buy
7,383
+1,222
+20% +$288K 0.02% 269
2024
Q3
$1.69M Sell
6,161
-516
-8% -$142K 0.02% 272
2024
Q2
$1.62M Sell
6,677
-12,360
-65% -$3M 0.02% 270
2024
Q1
$2.85M Buy
19,037
+6
+0% +$897 0.03% 240
2023
Q4
$3.64M Buy
19,031
+5,080
+36% +$972K 0.04% 237
2023
Q3
$2.47M Buy
13,951
+2,393
+21% +$424K 0.03% 258
2023
Q2
$2.2M Buy
11,558
+486
+4% +$92.3K 0.03% 266
2023
Q1
$2.22M Sell
11,072
-129
-1% -$25.8K 0.03% 282
2022
Q4
$2.66M Buy
11,201
+260
+2% +$61.8K 0.03% 283
2022
Q3
$2.19M Sell
10,941
-15,324
-58% -$3.07M 0.03% 304
2022
Q2
$3.83M Buy
26,265
+26
+0.1% +$3.79K 0.04% 257
2022
Q1
$4.29M Buy
26,239
+21,671
+474% +$3.54M 0.04% 258
2021
Q4
$775K Sell
4,568
-6
-0.1% -$1.02K 0.01% 365
2021
Q3
$864K Buy
4,574
+330
+8% +$62.3K 0.01% 362
2021
Q2
$719K Hold
4,244
0.01% 387
2021
Q1
$599K Buy
4,244
+10
+0.2% +$1.41K 0.01% 399
2020
Q4
$550K Buy
4,234
+77
+2% +$10K 0.01% 399
2020
Q3
$605K Sell
4,157
-62
-1% -$9.02K 0.01% 380
2020
Q2
$625K Hold
4,219
0.01% 398
2020
Q1
$459K Sell
4,219
-1
-0% -$109 0.01% 415
2019
Q4
$486K Sell
4,220
-97
-2% -$11.2K ﹤0.01% 442
2019
Q3
$347K Sell
4,317
-3
-0.1% -$241 ﹤0.01% 489
2019
Q2
$313K Hold
4,320
﹤0.01% 625
2019
Q1
$404K Sell
4,320
-211
-5% -$19.7K ﹤0.01% 595
2018
Q4
$330K Buy
4,531
+667
+17% +$48.6K ﹤0.01% 616
2018
Q3
$338K Hold
3,864
﹤0.01% 620
2018
Q2
$381K Sell
3,864
-37
-0.9% -$3.65K ﹤0.01% 616
2018
Q1
$465K Buy
3,901
+330
+9% +$39.3K ﹤0.01% 602
2017
Q4
$454K Buy
+3,571
New +$454K ﹤0.01% 614